| Autor: |
Sinisa, Miljković, Drasko, Prtina, Tamara, Rabi Zikić, Zoran, Vujković, Dusko, Racić, Vlado, Dajić, Aleksandar, Jesić, Milan, Arbutina, Milorad, Zikić |
| Rok vydání: |
2010 |
| Předmět: |
|
| Zdroj: |
Acta clinica Croatica. 49(2) |
| ISSN: |
0353-9466 |
| Popis: |
In this paper, we report our experience from a prospective study in 40 ischemic stroke patients admitted during the last two years at University Department of Neurology Stroke Unit, Banja Luka Clinical Center, in order to assess the safety and efficacy of thrombolytic therapy, the impact of age, sex and risk factors, and functional outcome at 6 months of intravenous tissue plasminogen activator treatment. According to the National Institutes of Health Stroke Scale, there were 5 mild, 22 moderate and 13 severe stroke cases in the study group. The outcome measures at 6 months of thrombolytic treatment were taken in 38 (100%) patients, yielding a Functional Independent Measure scoreor=90 (good clinical outcome) in 21 (52.50%) and modified Rankin Scoreor =2 (good clinical outcome) in 22 (55%) patients. The rate of symptomatic intracerebral hemorrhage in tissue plasminogen activator treated patients was 5%, with a mortality rate of 17.50%. The outcomes were comparable with those found in the NINDS t-PA trial. Current guidelines recommend a 'door-to-needle' time of less than 60 minutes and emphasize that 'time is brain'. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
